Ineffective erythropoiesis and thalassemias

Curr Opin Hematol. 2009 May;16(3):187-94. doi: 10.1097/MOH.0b013e32832990a4.

Abstract

Purpose of review: In thalassemia, ineffective erythropoiesis is characterized by apoptosis of the maturing nucleated erythroid cells. New studies also suggest that limited erythroid cell differentiation plays a role in the development of ineffective erythropoiesis. This would further exacerbate anemia and increase iron absorption.

Recent findings: During erythroid differentiation and maturation, it is critical that the components of hemoglobin are made in stoichiometric amounts. It is, therefore, conceivable that factors that modify this process intrinsically or extrinsically will also affect erythropoiesis. Several proteins have the potential to alter erythroid replication and differentiation in conditions of ineffective erythropoiesis. Elevated erythropoietin levels increase the number of erythroid precursors bearing a phosphorylated form of Jak2. This, in a pathological condition, may contribute to limited erythroid differentiation. Unbalanced synthesis of globins and heme modifies the activity of the heme-regulated inhibitor kinase, affecting proliferation and differentiation of the erythroid precursors. In addition, inefficient elimination of reactive oxygen species, which are increased under conditions of iron overload, may also hamper erythropoiesis.

Summary: Use of Jak2 inhibitors may limit the overproduction of immature erythroid cells in thalassemia, with the potential of reversing extramedullary hematopoiesis and preventing splenectomy. In addition, preventing iron overload and formation of reactive oxygen species may also be beneficial in limiting tissue damage and ineffective erythropoiesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Differentiation
  • Erythroid Cells / pathology
  • Erythropoiesis / physiology*
  • Globins / metabolism
  • Hematopoiesis, Extramedullary / physiology
  • Heme / metabolism
  • Humans
  • Iron / metabolism
  • Janus Kinase 2 / antagonists & inhibitors
  • Janus Kinase 2 / metabolism
  • Liver / metabolism
  • Mice
  • Reactive Oxygen Species / metabolism
  • Spleen / metabolism
  • Thalassemia / blood*

Substances

  • Reactive Oxygen Species
  • Heme
  • Globins
  • Iron
  • JAK2 protein, human
  • Janus Kinase 2